The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of tumor infiltrating lymphocytes (TILs) and stromal CD68 on trastuzumab (T) benefit in early stage HER2 positive breast cancer (BC).
 
Jacques Raphael
No Relationships to Disclose
 
Inna Y Gong
No Relationships to Disclose
 
Sharon Nofech-Mozes
No Relationships to Disclose
 
John M. S. Bartlett
Consulting or Advisory Role - BioNTech; Insight Genetics
Patents, Royalties, Other Intellectual Property - We have filed two patents relating to biomarkers in breast cancer. (Inst)
 
Houman Nafisi
No Relationships to Disclose
 
Sunil Verma
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Amgen; AstraZeneca; Eisai; Lilly; Novartis; Roche/Genentech
Speakers' Bureau - Novartis
Research Funding - Sanofi